Stock Market – Reddit

by /u/StockTipsTips on October 18, 2021 at 4:27 am

submitted by /u/StockTipsTips [link] [comments]

by /u/MyFunGa on October 18, 2021 at 4:20 am

This is very interesting. I’d like to hear feedback from people that own this vehicle. How is the crypto mining going? The base “Deluxe” model starts at around $20,000 while the luxe carbon-fiber “Ultimate” version will set you back $149,000. I hope that the owners of this vehicle are getting their money back from mining. The new light electric vehicle (LEV), dubbed the Spiritus, will be equipped with high-tech mining hardware and blockchain technology that will allow it to mine all kinds of crypto, from Bitcoin to Dogecoin, while it’s charging. For those unversed in crypto lingo, mining is a way of earning cryptocurrencies by solving cryptographic equations and algorithms through computers. You can mine via any computer, including the one onboard this pioneering ride. The Spiritus will include a GPU (processor) that supports a patent-pending system known as the Daymak Nebula. The Nebula comprises a miner that collects the coins and a digital wallet that stores them for future use. Naturally, there’s also an app that displays all the crypto info on your smartphone. “We envision a future where your highway tolls, your parking and your drive-thru order will be paid directly on the fly with crypto. Your online bills and your banking can be handled through the same software platform paid in crypto,” Daymak president Aldo Baiocchi said in a statement. “And whereas most vehicles are depreciating while they sit in your garage, the Nebula Miner will make you money while your Spiritus is parked.” According to the automaker, the emissions-free daily driver is also fitted with solar panels, which means the mining could be carried out using renewable energy rather than traditional fossil fuels. Recently, there has been some criticism regarding the environmental cost of mining crypto, but using solar power prevents all of that. As for the car itself, it has a decidedly futuristic aesthetic with sleek lines and a sculpted rear end. Though it only has three wheels, it’s certainly no slouch. The range-topping “Ultimate” model features an 80 kWh battery that delivers up to 150 hp. Daymak says this allows the svelte two-seater to go from zero to 60 in a breakneck 1.8 seconds and reach a top speed in excess of 130 mph. The company also claims the car can cover some 300 miles and charge in under two hours. https://robbreport.com/motors/cars/daymak-futuristic-new-ev-mines-cryptocurrency-while-charging-1234616964/ submitted by /u/MyFunGa [link] [comments]

by /u/VikingMasterXYZ on October 18, 2021 at 2:52 am

submitted by /u/VikingMasterXYZ [link] [comments]

by /u/abelahunter on October 18, 2021 at 2:00 am

submitted by /u/abelahunter [link] [comments]

by /u/SituationLive4406 on October 18, 2021 at 2:00 am

Medigus (MDGS) is Trading Below Book Value, Enters NFT Space and an Acquisition Good day everyone, There are a lot of companies that pay lip service to “creating shareholder value,” but every so often I come across one that backs that promise up with actions. Medigus Ltd. (NASDAQ: MDGS), is a technologies company that is focused on innovative growth partnerships, in advanced medical solutions, digital commerce, and electric vehicle markets. Current price $1.45/share (as of market close 10-15-21) In 2019 MDGS was a company with two technologies that were dynamic and innovative but weren’t commercially successful. That is when the company began the transformation to its current business model that has now come to fruition and is still growing. I talked about MDGS a month ago. I want to update you as to what has been happening at the company because it, once again, seems positioned for a near term gain in value. There has been a consolidation in the company’s market value, news from some of the partners it has invested in, and not least of all, a new, informative website. MDGS has 23M shares outstanding and in the float. H1 2021 Results: (for the six months ending June 30th) Revenues $2.4M Net Profit $7.9M (the MDGS market value is only $34.5M) Cash & Equiv. $29.6M I want to further discuss that MDGS transformation we discussed last month, but first I want to point out a few reasons I think the MDGS value could rise significantly in the near-term. I looked at the company 6-K for the period ending June 30, 2021, filed on September 20, 2021. I assume any material changes before the filing date would have been reported. This metric stood out! MDGS reports shareholders equity of $53.9M which represents a book value of $2.17/share. The current market cap/share price is 34% below this level. The investments made by MDGS during their company transition have been lucrative. Not all of them yet, but a few are contributing, not necessarily to the top line, but nicely to the company’s bottom line. An important part of your due diligence would be to familiarize yourself with these companies MDGS has invested in. ScoutCam Inc. is a public company (OTCQB: SCTC), an entity in which MDGS owns 27.76%. SCTC produces the smallest cameras produced in the world (down to 1mm diameter including illumination), ScoutCam devices are used across the medical, aerospace, industrial, research and defense industries. SCTC is currently valued at $56.8M making the MDGS investment worth $15.7M. Gix Internet is a public company (TASE: GIX), in which Medigus owns 33.17% on a fully diluted basis. GIX is a global marketing technology solutions company for online performance-based-marketing. GIX is currently valued at $55.6M making the MDGS investment worth $18.4M. The company just announced that Gix Internet’s subsidiary, Gix Media completed the acquisition of 70% of Cortex Group, an innovative media-tech company that has developed expertise in turning original content into a profit center through user traffic acquisition. Cortex has H1 2021 revenues over $13M and is profitable. It is worthy to note that the current combined value of the MDGS investment in these two public companies ($34.1M) is near the current market value of MDGS of $34.5M. Eventer Technologies Ltd. Is a private company 47.69% owned by MDGS. Eventer operates an online event management plugin and ticketing platform for the creation, management, promotion, ticketing, and billing of live and online events. Eventer has filed its first public prospectus draft for an IPO of its shares on the Tel Aviv Stock Exchange (TASE). Polyrizon Ltd. is a privately company in which Medigus owns 35.86%. Polyrizon’s technology is comprised of a bio-gel that is applied topically designed to safely prevent allergens and virus intrusion through the upper airways and eye cavities. Jeffs Brands Ltd. Is a private company and along with its subsidiaries Smart Repair Pro, Purex and Top Rank, is 50.03% owned by Medigus. Jeff’s Brands owns six branded products that it globally sells within their Fulfillment by Amazon shops. Jeff Brands just signed a non-binding collaboration agreement with iFulfillYou LLC, a U.S.-based warehousing logistics services company under which the parties intend to collaborate for the establishment of logistics warehouses in the U.S. Charging Robotics is a wholly owned subsidiary of Medigus developing a robotic platform for charging vehicles in a wireless and automatic manner without plugs or cables. No more searching for a parking spot with a charger. Revoltz is a privately held company that is 19.9% owned by MDGS (through Charging Robotics). The company develops electric micro-mobility vehicles and has completed a prototype of Model One, its micro mobility vehicle for last mile and food delivery. The companies above, that represent MDGS investments, are more fully described on the company website. Now the company has announced its intent to invest $400K for a 2.5% stake in Safee, a Non-Fungible Token (NFT) technology company. Safee’s social network will allow creators and collectors to easily trade digital goods. It will enable regular people and digital creators alike to monetize their creations in the digital world. The Medigus Ultrasonic Surgical Endostapler, or MUSE™ system, is an endoscopic device to deliver a more patient-friendly option for Transoral Fundoplication (TF), the procedure is intended to treat the leading cause of GERD (gastroesophageal reflux disease). MDGS developed this product before their transformation that began in 2019 and is currently focused on a licensing or sale agreement for the product. Stay tuned for more information on MDGS. Privacy policy and disclaimer submitted by /u/SituationLive4406 [link] [comments]

by /u/ini0n on October 18, 2021 at 1:42 am

submitted by /u/ini0n [link] [comments]

by /u/JellyfishComplete370 on October 18, 2021 at 12:26 am

​ Progenity, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. Case for Short-Squeeze Prog has one of the highest SI (about 64%) while only one entity is trying to keep the price suppressed (Athyrium). CTB continues to rise everyday as per Ortex data Ortex has issued all 3 signals of short-squeeze on Prog It’s a penny stock at a price that anyone who is in stock market investing can easily buy and hold to add to buying pressure. Price jump from 0.88 to 2.5 brought in a lot of 0.5, 1, and 1.5 calls option ITM for 10/15 The company shorting it doesn’t have unlimited money supply to keep the price suppressed unlike a hedgefund that can/does divert all their money to control any stock they want. Catalysts: Prog already got a patient approved October 5th but no PR because of the Athyium manipulation below (personal opinion). a. Evidence (Look at the date of recent patent) No unlimited money for Athyrium to short: Athyrium isn’t in core business of shorting to make money and continue to do until they win. This factor alone along with buying pressure will force them to wave white flag within days-not weeks. Why Athyrium is shorting is and is in trouble now. Athyrium has a pattern of suppressing price to buy low as many shares as they can to take control of the company and then sell at a premium (Evidence) However, this time around Athyrium gets caught with Prog where retail picked this stock and brought into light of short-squeeze play. Shorting means that this insider has to cover its short position eventually and they don’t have enough time and only hope is more share issue which is not happening until November 20th and actually may not even happen if squeeze happens before end of October. They hoped that retail eye won’t catch prog and hence they can cover lower when the time comes Evidence of Athyrium manipulation: (https://www.athyrium.com/case-study-verenium.php). This article clearly shows that Athyrium is not new to this and was able to do this before, only difference is that Prog got retail attention making it difficult to manipulate easily. a. Barcoding: The price is experiencing barcoding last whole week where it moves by 10 cents and then whole day is a move of max 4-5 cents each day. This is their tactic to continue buying lower to accumulate and hope retail pressure doesn’t come in. b. Way to break barcoding: With enough volume in even 1 day, tables will be turned and any price above $2.5 in coming week gives majority control to retail to make squeeze happen. Scenario 1 of Short Squeeze. 1. With enough volume (500 Mil to a billion), the play will be totally out of Athyrium’s hands because it can lead to a price range of $2.40-$3.25 hopefully this coming week. 2. This will force Athyrium to cover its position and trigger a gamma-squeeze effect prior to 10/15. Scenario 2 of Short Squeeze. 1. Continuing with first scenario, the price will be in $5 and above range in following week of 10/15 2. Buyout option is still on the table which means Prog can never be sold under $5 and price decided for buyout is $8-$10 so every retail investor makes money while Athyrium goes home defeated with their lesser shares and whatever price. Scenario 3 of Short Squeeze. 1. The buying pressure from scenario 3 continues leading the prog price in high double digits, leading to no share issue possibility at all and buyout still happens which means still atleastt 50%-70% premium on that price (Let’s say $25 + 50%-70%). Scenario 4 of Short Squeeze (Least desirable for retail investors). 1. Athyirum continues to do its shit plan and keeps price down before buyout. They will cover at lower cost and everyone holding shares makes just good enough profit at $4 price buyout. How to make squeeze happen: Significant ITM calls buy volume for those who love option play. One day of 300-500 Mil in volume with buying pressure to just start the squeeze this week submitted by /u/JellyfishComplete370 [link] [comments]